Grace Therapeutics, Inc. (GRCE) stock
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
$1.73+0.01 (+0.58%)
Close on Nov 18, 2026Market cap $36.39MP/E –Yield –
Grace Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Grace Therapeutics's gross profit for the twelve months ending Mar 31, 2022 was $100.00M, up 83233.3% year over year. For fiscal 2022 it was $100.00M, up 83233.3% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | $100.00M | +83233.3% |
| FY2021 | Mar 31, 2021 | $120.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $100.00M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $0 | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $75.00K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $45.00K | – |
See a number that looks wrong?